Volunteer Assignments and Opportunities: Difference between revisions
| [checked revision] | [unchecked revision] |
No edit summary |
Kgeiersbach (talk | contribs) updated page assignments |
||
| Line 3,532: | Line 3,532: | ||
| | | | ||
|- | |- | ||
|Adenoid Cystic Carcinoma||Disease||Katherine Geiersbach | |Adenoid Cystic Carcinoma||Disease||Katherine Geiersbach and Jun Liao | ||
|10/12/02022 | |10/12/02022 | ||
| | |11/11/2023 | ||
|PENDING | |PENDING | ||
| | | | ||
| Line 3,543: | Line 3,543: | ||
|Secretory Carcinoma||Disease||Hui Chen | |Secretory Carcinoma||Disease||Hui Chen | ||
|10/12/2022 | |10/12/2022 | ||
| | |11/11/2023 | ||
|PENDING | |PENDING | ||
| | | | ||
| Line 3,569: | Line 3,569: | ||
|- | |- | ||
|Tall Cell Carcinoma with Reversed Polarity||Disease||H. Evin Gulbahce | |Tall Cell Carcinoma with Reversed Polarity||Disease||H. Evin Gulbahce | ||
| | |8/11/2023 | ||
| | |10/11/2023 | ||
|PENDING | |PENDING | ||
| | | | ||
| Line 3,604: | Line 3,604: | ||
| | | | ||
|- | |- | ||
|Fibroadenoma||Disease|| | |Fibroadenoma||Disease||H. Evin Gulbahce / Patricija Zot | ||
| | |8/11/2023 | ||
| | |10/11/2023 | ||
| | | | ||
| | | | ||
|Hui Chen | |||
| | | | ||
| | | | ||
|- | |- | ||
|Phyllodes Tumour||Disease|| | |Phyllodes Tumour||Disease||H. Evin Gulbahce / Patricija Zot / Emilie Lalonde | ||
| | |8/11/2023 | ||
| | |10/11/2023 | ||
| | | | ||
| | | | ||
|Hui Chen | |||
| | | | ||
| | | | ||
| Line 3,721: | Line 3,721: | ||
| | | | ||
|- | |- | ||
|Inflammatory Myofibroblastic Tumour||Disease|| | |Inflammatory Myofibroblastic Tumour||Disease||Yajuan Liu | ||
| | |8/11/2023 | ||
| | |11/11/2023 | ||
| | | | ||
| | | | ||
|Hui Chen | |||
| | | | ||
| | | | ||
| Line 3,892: | Line 3,892: | ||
| | | | ||
|- | |- | ||
|BRCA1/2-Associated Hereditary Breast and Ovarian Cancer Syndrome||Disease|| | |BRCA1/2-Associated Hereditary Breast and Ovarian Cancer Syndrome||Disease||Constance Albarracin | ||
| | |8/11/2023 | ||
| | |11/11/2023 | ||
| | | | ||
| | | | ||
|Katherine Geiersbach | |||
| | | | ||
| | | | ||
| Line 3,910: | Line 3,910: | ||
| | | | ||
|- | |- | ||
|Ataxia-Telangiectasia||Disease|| | |Ataxia-Telangiectasia||Disease||Evin Gulbahce | ||
| | |8/11/2023 | ||
| | |11/11/2023 | ||
| | | | ||
| | | | ||
|Katherine Geiersbach | |||
| | | | ||
| | | | ||
| Line 3,946: | Line 3,946: | ||
| | | | ||
|- | |- | ||
|PALB2-Associated Cancers||Disease|| | |PALB2-Associated Cancers||Disease||Katherine Geiersbach | ||
| | |10/2/2023 | ||
| | |1/2/2024 | ||
| | | | ||
| | | | ||
|Katherine Geiersbach | |||
| | | | ||
| | | | ||